BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34143952)

  • 1. Bi-allelic variants in the ER quality-control mannosidase gene EDEM3 cause a congenital disorder of glycosylation.
    Polla DL; Edmondson AC; Duvet S; March ME; Sousa AB; Lehman A; ; Niyazov D; van Dijk F; Demirdas S; van Slegtenhorst MA; Kievit AJA; Schulz C; Armstrong L; Bi X; Rader DJ; Izumi K; Zackai EH; de Franco E; Jorge P; Huffels SC; Hommersom M; Ellard S; Lefeber DJ; Santani A; Hand NJ; van Bokhoven H; He M; de Brouwer APM
    Am J Hum Genet; 2021 Jul; 108(7):1342-1349. PubMed ID: 34143952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ER-resident protein 46 (ERp46) triggers the mannose-trimming activity of ER degradation-enhancing α-mannosidase-like protein 3 (EDEM3).
    Yu S; Ito S; Wada I; Hosokawa N
    J Biol Chem; 2018 Jul; 293(27):10663-10674. PubMed ID: 29784879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired catabolism of free oligosaccharides due to MAN2C1 variants causes a neurodevelopmental disorder.
    Maia N; Potelle S; Yildirim H; Duvet S; Akula SK; Schulz C; Wiame E; Gheldof A; O'Kane K; Lai A; Sermon K; Proisy M; Loget P; Attié-Bitach T; Quelin C; Fortuna AM; Soares AR; de Brouwer APM; Van Schaftingen E; Nassogne MC; Walsh CA; Stouffs K; Jorge P; Jansen AC; Foulquier F
    Am J Hum Genet; 2022 Feb; 109(2):345-360. PubMed ID: 35045343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming.
    Hirao K; Natsuka Y; Tamura T; Wada I; Morito D; Natsuka S; Romero P; Sleno B; Tremblay LO; Herscovics A; Nagata K; Hosokawa N
    J Biol Chem; 2006 Apr; 281(14):9650-8. PubMed ID: 16431915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAN1B-CDG: Novel variants with a distinct phenotype and review of literature.
    Balasubramanian M; Johnson DS;
    Eur J Med Genet; 2019 Feb; 62(2):109-114. PubMed ID: 29908352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDEM3 Domains Cooperate to Perform Its Overall Cell Functioning.
    Manica G; Ghenea S; Munteanu CVA; Martin EC; Butnaru C; Surleac M; Chiritoiu GN; Alexandru PR; Petrescu AJ; Petrescu SM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
    Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
    Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified EDEM3 or EDEM1 alone produces determinant oligosaccharide structures from M8B in mammalian glycoprotein ERAD.
    George G; Ninagawa S; Yagi H; Furukawa JI; Hashii N; Ishii-Watabe A; Deng Y; Matsushita K; Ishikawa T; Mamahit YP; Maki Y; Kajihara Y; Kato K; Okada T; Mori K
    Elife; 2021 Oct; 10():. PubMed ID: 34698634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency.
    Saldova R; Stöckmann H; O'Flaherty R; Lefeber DJ; Jaeken J; Rudd PM
    J Proteome Res; 2015 Oct; 14(10):4402-12. PubMed ID: 26401844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro mannosidase activity of EDEM3 against asparagine-linked oligomannose-type glycans.
    Kikuma T; Ibuki H; Nakamoto M; Seko A; Ito Y; Takeda Y
    Biochem Biophys Res Commun; 2022 Jul; 612():44-49. PubMed ID: 35500441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAN1B1 deficiency: an unexpected CDG-II.
    Rymen D; Peanne R; Millón MB; Race V; Sturiale L; Garozzo D; Mills P; Clayton P; Asteggiano CG; Quelhas D; Cansu A; Martins E; Nassogne MC; Gonçalves-Rocha M; Topaloglu H; Jaeken J; Foulquier F; Matthijs G
    PLoS Genet; 2013; 9(12):e1003989. PubMed ID: 24348268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the translocon-associated protein complex subunit SSR3 cause a novel congenital disorder of glycosylation.
    Ng BG; Lourenço CM; Losfeld ME; Buckingham KJ; Kircher M; Nickerson DA; Shendure J; Bamshad MJ; ; Freeze HH
    J Inherit Metab Dis; 2019 Sep; 42(5):993-997. PubMed ID: 30945312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer.
    Scott E; Garnham R; Cheung K; Duxfield A; Elliott DJ; Munkley J
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Mannosidase Assay of EDEMs: ER Degradation-Enhancing α-Mannosidase-Like Proteins.
    Hosokawa N
    Methods Mol Biol; 2020; 2132():151-158. PubMed ID: 32306323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.
    Ng BG; Sosicka P; Fenaille F; Harroche A; Vuillaumier-Barrot S; Porterfield M; Xia ZJ; Wagner S; Bamshad MJ; Vergnes-Boiteux MC; Cholet S; Dalton S; Dell A; Dupré T; Fiore M; Haslam SM; Huguenin Y; Kumagai T; Kulik M; McGoogan K; Michot C; Nickerson DA; Pascreau T; Borgel D; Raymond K; Warad D; ; Flanagan-Steet H; Steet R; Tiemeyer M; Seta N; Bruneel A; Freeze HH
    Am J Hum Genet; 2021 Jun; 108(6):1040-1052. PubMed ID: 33964207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EDEM2 initiates mammalian glycoprotein ERAD by catalyzing the first mannose trimming step.
    Ninagawa S; Okada T; Sumitomo Y; Kamiya Y; Kato K; Horimoto S; Ishikawa T; Takeda S; Sakuma T; Yamamoto T; Mori K
    J Cell Biol; 2014 Aug; 206(3):347-56. PubMed ID: 25092655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of N-glycan processing modulates the network of EDEM3 interactors.
    Butnaru CM; Chiritoiu MB; Chiritoiu GN; Petrescu SM; Petrescu AJ
    Biochem Biophys Res Commun; 2017 May; 486(4):978-984. PubMed ID: 28366632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency.
    Van Scherpenzeel M; Timal S; Rymen D; Hoischen A; Wuhrer M; Hipgrave-Ederveen A; Grunewald S; Peanne R; Saada A; Edvardson S; Grønborg S; Ruijter G; Kattentidt-Mouravieva A; Brum JM; Freckmann ML; Tomkins S; Jalan A; Prochazkova D; Ondruskova N; Hansikova H; Willemsen MA; Hensbergen PJ; Matthijs G; Wevers RA; Veltman JA; Morava E; Lefeber DJ
    Brain; 2014 Apr; 137(Pt 4):1030-8. PubMed ID: 24566669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
    Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
    Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing.
    Timal S; Hoischen A; Lehle L; Adamowicz M; Huijben K; Sykut-Cegielska J; Paprocka J; Jamroz E; van Spronsen FJ; Körner C; Gilissen C; Rodenburg RJ; Eidhof I; Van den Heuvel L; Thiel C; Wevers RA; Morava E; Veltman J; Lefeber DJ
    Hum Mol Genet; 2012 Oct; 21(19):4151-61. PubMed ID: 22492991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.